Study: Long-term blood pressure variability and visual field progression in glaucoma

News
Article

A retrospective cohort study was designed to provide further information on the association between BP parameters and VF progression over time.

Female patient getting blood pressure taken in doctor's office Image credit: AdobeStock/bnenin

Image credit: AdobeStock/bnenin

A newly published study1 reported that higher mean blood pressure (BP) levels and higher standard deviation (SD) of BP are associated with faster progression of visual field (VF) defects in patients with glaucoma.

Vincent Q. Pham, BS, and colleagues from the Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center, Shiley Eye Institute, University of California, San Diego, La Jolla, CA, reported their results in JAMA Ophthalmology.

They pointed out that the association between blood pressure (BP) and glaucoma progression has been studied previously.2,3 Impaired autoregulation of the vasculature, especially in the optic nerve head, was proposed as a key risk factor for glaucomatous progression.4 However, it remains uncertain whether these vascular changes are a cause or a consequence of glaucoma, they commented.

Blood pressure study and findings

This was a retrospective cohort study designed to provide further information on the association between BP parameters and VF progression over time. The study included patients with suspected or confirmed glaucoma who had been part of the Diagnostic Innovations in Glaucoma Study and the African Descent and Glaucoma Evaluation Study. BP and VF testing was performed from November 2000 to December 2022.

The main outcome measures were the mean and SD values of the systolic and diastolic arterial pressures, which were incorporated into multivariable mixed-effect models to look at association between BP parameters and mean intraocular pressure (IOP) with rates of VF mean deviation loss. The BP parameters, including the mean arterial pressure (MAP), systolic arterial pressure (SAP), and diastolic arterial pressure (DAP) were analyzed, according to the authors, in 3 separate models each incorporating their mean values and SDs. Two-way interaction terms and 3-way interaction terms for each combination of the mean BP, SD of the BP, and the mean IOP were included in the multivariable analysis.

The cohort included 1,674 eyes of 985 patients (mean age, 61.2 years).

The investigators reported that the mean change in the VF mean deviation was −0.13 (95% confidence interval [CI], −0.16 to −0.10) decibels (dB) annually over a mean follow-up of 8.0 years.

The interaction terms of higher mean BP and higher SD of the BP were associated with faster annual mean deviation changes for the MAP (0.02; 95% CI, 0.01-0.04 dB annually per 1-mm Hg higher; P = 0.001) and DAP (0.02; 95% CI, 0.01-0.03 dB annually per 1-mm Hg higher; P < 0.001). The interaction term of the higher SD of the BP and higher mean IOP was associated with faster annual mean deviation changes for the MAP (0.01; 95% CI, 0.00-0.02 μm per 1-mm Hg higher; P = 0.003) and DAP (0.01; 95% CI, 0.00-0.01 μm per 1-mm Hg higher; P = 0.001).

The authors concluded, “In this cohort study, the higher mean BP and higher SD of blood pressure were associated with faster VF progression. These findings suggest that long-term variability of the BP may be a modifier of the association between the IOP and VF progression in glaucoma.”

References:
  1. Pham VQ, Nishida T, Moghimi S, et al.Long-term blood pressure variability and visual field progression in glaucoma. JAMA Ophthalmol. Published online November 14, 2024. doi:10.1001/jamaophthalmol.2024.4868
  2. Mohammadzadeh V, Su E, Mohammadi M, et al. Association of blood pressure with rates of macular ganglion cell complex thinning in patients with glaucoma. JAMA Ophthalmol. 2023;141:251-257. doi:10.1001/jamaophthalmol.2022.6092
  3. Jammal AA, Berchuck SI, Mariottoni EB, et al. Blood pressure and glaucomatous progression in a large clinical population. Ophthalmology. 2022;129:161-170. doi:10.1016/j.ophtha.2021.08.021
  4. Leung DYL, Tham CC. Normal-tension glaucoma: current concepts and approaches-A review. Clin Exp Ophthalmol. 2022;50:247-259. doi:10.1111/ceo.14043

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Drs Brianna Rhue and Diana Canto-Sims discuss the benefits of implementing a contact lens management system that can help improve lens sales at your practice.
Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD; detailed what optometrists can expect to change when HB 1353's regulations are enacted later this year.
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
© 2025 MJH Life Sciences

All rights reserved.